Insulin-like growth factors and risk of benign prostatic hyperplasia-Reference-Cited by-同舟云学术

Insulin-like growth factors and risk of benign prostatic hyperplasia

Published:2002-07-01 Issue:2 Volume:52 Page:98-105
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Chokkalingam Anand P.,Gao Yu-Tang,Deng Jie,Stanczyk Frank Z.,Sesterhenn Isabell A.,Mostofi F.K.,Fraumeni Joseph F.,Hsing Ann W.

Publisher

Wiley

Subject

Urology,Oncology

Reference26 articles.

1. The Development of Human Benign Prostatic Hyperplasia with Age

2. Epidemiology, etiology, pathophysiology, and diagnosis of benign prostatic hyperplasia. In: editors. Campbell's urology. 7th ed. Philadelphia: WB Saunders Company; 1998. p 1429-1452.

3. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis

4. Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of BPH: Symptom Relief with Dietary Polyphenols, Vitamins and Phytochemicals by Nutraceutical Supplements with Implications to the Prostate Microbiome;International Journal of Molecular Sciences;2023-03-13

2. Circulating insulin-like growth factor-I and risk of 25 common conditions: outcome-wide analyses in the UK Biobank study;European Journal of Epidemiology;2021-11-08

3. Association of decreased sperm motility and increased seminal plasma IGF-I, IGF-II, IGFBP-2, and PSA levels in infertile men;Endocrine;2021-07-17

4. An investigation on the relevance of prolactin, insulin‐like growth factor‐1 and 25‐hydroxyvitamin D 3 (25‐OHD 3 ) in canine benign prostatic hyperplasia in a predisposed breed model;Veterinary Medicine and Science;2021-05-20

5. Circulating insulin-like growth factor-I and risk of 25 common conditions: outcome-wide analyses in the UK Biobank Study;2021-05-10